AstraZeneca, J&J resuming US tests of Covid-19 vaccines
Two drugmakers announced Friday the resumption of U.S. testing of their Covid-19 vaccine candidates. Testing of AstraZeneca‘s vaccine candidate had been halted since early September,...
astrazeneca
Bharat Biotech in talks to take COVID-19 vaccine candidate global
BENGALURU: India’s Bharat Biotech is in discussions with more than 10 countries that have shown an interest in a potential COVID-19 vaccine it is developing...
Britain partners with Oxford firm to assess coronavirus vaccine T cell responses
LONDON: Britain on Thursday said it would partner with an Oxford-based firm to provide testing for the T cell response of coronavirus vaccine candidates to...
AstraZeneca Covid-19 vaccine trial Brazil volunteer dies, trial to continue
SAO PAULO/FRANFURT: Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the Covid-19 vaccine developed by AstraZeneca and Oxford...
Moderna CEO expects Covid-19 vaccine interim results in November
Moderna Inc Chief Executive Officer Stéphane Bancel expects interim results from its Covid-19 vaccine trial in November and that the U.S government could give an...
Pfizer, BioNTech start combined trials of Covid-19 vaccine candidate in Japan
TOKYO: Pfizer Inc and BioNTech SE announced on Tuesday the start in Japan of combined Phase I and Phase II clinical trials of their mRNA...
Hope of Covid-19 vaccine deployment in UK by New Year: Report
LONDON: One of the UK’s senior-most medical chiefs has indicated that a vaccine against Covid-19 could be ready to be deployed by the start of...
3 COVID-19 trials have been paused for safety. That’s a good thing
By Carl Zimmer This week, two high-profile, late-stage clinical trials — Johnson & Johnson’s test of a coronavirus vaccine and Eli Lilly’s study of a...
Eli Lilly taps Fujifilm to chip in on COVID-19 antibody manufacturing as it awaits FDA’s emergency use decision
Shortly after rolling out interim data on its COVID-19 antibody hopeful, Eli Lilly last week sent the therapy ahead to the FDA for a potential...
Johnson & Johnson pauses Covid vaccine trial as participant becomes ill
WASHINGTON: Johnson & Johnson said on Monday it had temporarily paused its Covid-19 vaccine candidate clinical trials due to an unexplained illness in a study...